Urine toxicology screening among chronic pain patients on opioid therapy: Frequency and predictability of abnormal findings

Clinical Journal of Pain

Volumn 23, Issue 2, 2007, Pages 173-179

  Michna, Edward ^a   Jamison, Robert N ^a   Pham, Loc Duyen ^a   Ross, Edgar L ^a   Janfaza, David ^a   Nedeljkovic, Srdjan S ^a   Narang, Sanjeet ^a   Palombi, Diane ^a   Wasan, Ajay D ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

Author keywords

Adherence; Chronic pain; Misuse; Opioid therapy; Opioids; Substance abuse; Urine testing; Urine toxicology screens

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CANNABIS; COCAINE; CODEINE; DEXTROPROPOXYPHENE; DIAMORPHINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; LONG ACTING DRUG; METHADONE; MORPHINE; OPIATE; OXYCODONE; SHORT ACTING DRUG;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PREDICTIVE VALIDITY; PREDICTOR VARIABLE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBSTANCE ABUSE; TEACHING HOSPITAL; TOXICOLOGY; URBAN AREA; URINALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES; STREET DRUGS;

EID: 33846437873     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31802b4f95     Document Type: Article

References (27)

1. Ehrlich GE. Back pain. J Rheumatol Suppl. 2003;67:26-31.
2. Joranson DE, GIbson AM. Policy issues and imperatives in the use of opioids to treat pain in substance abusers. J Law Med Ethics. 1994;22:215-223.
3. Ferrari R, Russell AS. Regional musculoskeletal conditions: neck pain. Best Pract Res Clin Rheumatol. 2003;17:57-70.
4. Jamison RN, Raymond SA, Slawsby EA, et al. Opioid therapy for chronic noncancer back pain. Spine. 1998;23:2591-2600.
5. AAPM. American Academy of Pain Medicine and American Pain Society consensus statement: the use of opioids for the treatment of chronic pain. Pain Forum. 1997;77-79.
6. Manchikanti L, Fellows B, Damron KS, et al. Prevalence of illicit drug use among individuals with chronic pain in the commonwealth of Kentucky: an evaluation of patterns and trends. J KY Med Assoc. 2005;103:55-62.
7. Joranson DE, Ryan KM, Gilson AM, et al. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283:1710-1714.
8. Gilson AM, Ryan KM, Joranson DE, et al. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004;28:176-188.
9. Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000;19:53-62.
10. Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004;28:250-258.
11. Nedeljkovic SS, Wasan AD, Jamison RN. Assessment of efficacy of long-term opioid therapy in pain patients with substance abuse potential. Clin J Pain. 2002;18:S39-S51.
12. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:77-85.
13. Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage. 2004;27:260-267.
14. Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97:1097-1102.
15. Berndt S, Maier C, Schutz HW. Polymedication and medication Compliance in patients with chronic non-malignant pain. Pain. 1993;52:331-339.
16. Passik SD, Schreiber J, Kirsh KL, et al. A chart review of the ordering and documentation of urine toxicology screens in a cancer center: do they influences patient management? J Pain Symptom Manage. 2000;19:40-44.
17. Preston KL, Silverman K, Schulter CR, et al. Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies. NIDA RE Monog. 1997;167:130-145.
18. Fishbain DA, Cutler RB, Rosomoff HL, et al. Validity of self-reported drug use in chronic pain patients. Clin J Pain. 1999;15:184-191.
19. Caldwell R, Challenger H. A capillary column gas-chromatographic method for the identification of drugs of abuse in urine samples. Ann Clin Biochem. 1989;26:430-443.
20. Cone EJ, Heit HA, Caplan YH, et al. Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine. J Anal Toxicol. 2006;30:1-5.
21. Jamison RN, Schein JR, Vallow R, et al. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Sympt Manage. 2003;26:913-921.
22. Ballantyne J, Mao J. Opioid Therapy for Chronic Pain. NEJM. 2003;349:1943-1953.
23. Savage S. Addiction and pain: assessment and treatment issues. Clin J Pain. 2002;18(4 suppl):S28-S38.
24. Butler SF, Budman SH, Fernandez K, et al. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112:65-75.
25. Passik SD, Kirsh KL, Whitcomb L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. (PADT) Clin Ther. 2004;26:552-561.
26. Adams LL, Gatchel RJ, Robinson RC, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004:440-459.
27. Model Policy for the Use of Controlled Substances for the Treatment of Pain, in Federation of State Medical Boards. Washington, DC; 2004:1-5.